StackWave Affinity
StackWave Affinity v16: Next Generation Sequencing
StackWave Affinity v16 Announcement - Next Generation Sequencing
StackWave Blog
Software for Antibody Discovery
Therapeutic Discovery
Utilizing Nanobodies for Targeting Cancer - An In-Depth Look
An emerging therapeutic strategy to tackle cancer is nanobodies – small, single-domain antibody fragments derived from heavy-chain-only antibodies.
Therapeutic Discovery
The Discovery and Development of Nanobodies as Therapeutic Agents
Nanobodies, also known as single-domain antibodies or VHHs, are small, highly stable, and specific antibody fragments.
Antibody Discovery
Bulk B Cell Analysis via NGS for Antibody Discovery
Bulk B cell analysis is a powerful tool for antibody discovery because it provides a snapshot of the entire B cell population at a given time.
ADME
Back-calculating Concentration of Antibody from Standard Curve for Pharmacokinetics
In pharmacokinetics, standard curves are used to determine the concentration of a drug in biological fluids such as blood or plasma.
Therapeutic Discovery
The Revolutionary Use of Antibody-Drug Conjugates in Cancer Therapy
ADCs are essentially a new class of drugs that combine the targeting properties of antibodies with the cell-killing ability of drugs.
Antibody Discovery
The Role of Antibodies in Therapeutic Drug Discovery
Monoclonal antibodies are revolutionizing therapeutics with their precision and specificity, allowing for safer treatment of a variety of diseases...
StackWave Affinity™ v15: Titration and Dose Response Experiments
StackWave Affinity v15 Announcement - Titration and Dose Response Experiments
StackWave Affinity
Assessing Tech in Biotech
The sunk cost fallacy can affect our decision making around LIMS, other software, and antibody discovery technology purchases.
StackWave Affinity
StackWave Affinity™
StackWave Affinity™ takes a fundamentally different approach than other software solutions to the unique challenges of Antibody Discovery teams.